Intellectual Property India Publishes Patent Application for A Multi-Mechanism Monoclonal Antibody Composition With Enhanced Pharmacokinetics And Stability

MUMBAI, India, July 30 -- Intellectual Property India has published a patent application (202641088060 A) filed by Dr. M. Sangeetha; and Dr. V. Uma Maheswara Rao on July 19, 2026, for A Multi-Mechanism Monoclonal Antibody Composition With Enhanced Pharmacokinetics And Stability.

Inventors include Dr. N. Madhavi; Mrs. G. Supriya; Mr. Roshan Ali; and Mrs. Lahari.

The application for the patent was published on July 24, 2026, under issue no. 30/2026.

Abstract: A multi-mechanism monoclonal antibody composition with enhanced pharmacokinetics and stability is disclosed. The system comprises a monoclonal antibody having an Fc region engineered for increased binding to neonatal Fc receptor (FcRn) to extend systemic circulation, a biodegradable c...